Literature DB >> 23030487

Sequence and structural basis for chromosomal fragility during translocations in cancer.

Vidya Gopalakrishnan1, Sathees C Raghavan.   

Abstract

Chromosomal aberration is considered to be one of the major characteristic features in many cancers. Chromosomal translocation, one type of genomic abnormality, can lead to deregulation of critical genes involved in regulating important physiological functions such as cell proliferation and DNA repair. Although chromosomal translocations were thought to be random events, recent findings suggest that certain regions in the human genome are more susceptible to breakage than others. The possibility of deviation from the usual B-DNA conformation in such fragile regions has been an active area of investigation. This review summarizes the factors that contribute towards the fragility of these regions in the chromosomes, such as DNA sequences and the role of different forms of DNA structures. Proteins responsible for chromosomal fragility, and their mechanism of action are also discussed. The effect of positioning of chromosomes within the nucleus favoring chromosomal translocations and the role of repair mechanisms are also addressed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030487     DOI: 10.2217/fon.12.107

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  4 in total

1.  Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Dan Wu; Honglei Jiang; Hao Yu; Dong Xu; Jian Liang; Junzhe Jin
Journal:  Tumour Biol       Date:  2013-07-20

2.  Detection of G-quadruplex DNA using primer extension as a tool.

Authors:  Rupa Kumari; Mridula Nambiar; Shaika Shanbagh; Sathees C Raghavan
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

3.  Injection of an SV40 transcriptional terminator causes embryonic lethality: a possible zebrafish model for screening nonhomologous end-joining inhibitors.

Authors:  Zhe Yang; Shihao Chen; Songlei Xue; Xinxiu Li; Jiang Hu; Zhen Sun; Hengmi Cui
Journal:  Onco Targets Ther       Date:  2018-08-17       Impact factor: 4.147

4.  Characterization of G-quadruplex antibody reveals differential specificity for G4 DNA forms.

Authors:  Saniya M Javadekar; Namrata M Nilavar; Amita Paranjape; Kohal Das; Sathees C Raghavan
Journal:  DNA Res       Date:  2020-12-03       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.